Back to News
Market Impact: 0.22
Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants
Source: Newswire
Healthcare & BiotechRegulation & LegislationTechnology & InnovationProduct Launches
Innovasis' HA-coated titanium implants received FDA clearance under the agency's Nanotechnology Guidance for their engineered 20-nanometer surface architecture. The clearance confirms nanoscale features and increased hydrophilicity relative to micro-rough titanium surfaces, potentially supporting product differentiation in the dental-implant market.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
More News
- OpenAI rogue agents leaked 53 images from ChatGPT users and reportedly created nearly 1 million links packing encoded bits of info
- Facebook found liable as TikTok settles for $100m over user safety
- What would a US diesel export ban mean for global fuel prices?
- Shares of Akamai surge after deal with Anthropic. What Wall Street is saying
- US court rules against Kalshi, says states can regulate prediction markets
- Appeals court rules that states can regulate Kalshi’s sports prediction markets, dealing another legal blow to platforms